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Neurobiology of Disease
Disruption of TrkB-Mediated Phospholipase C Signaling
Inhibits Limbic Epileptogenesis
Xiao Ping He,1 Enhui Pan,1 Carla Sciarretta,4 Liliana Minichiello,4,5 and James O. McNamara1,2,3
Departments of 1Medicine (Neurology), 2Neurobiology, and 3Pharmacology and Molecular Cancer Biology, Duke University Medical Center, Durham,
North Carolina 27710, 4European Molecular Biology Laboratory, Mouse Biology Unit, 00015 Monterotondo, Italy, and 5Centre for Neuroregeneration,
University of Edinburgh, Edinburgh EH16 4SB, United Kingdom
The BDNF receptor, TrkB, is critical to limbic epileptogenesis, but the responsible downstream signaling pathways are unknown. We
hypothesized that TrkB-dependent activation of phospholipase C1 (PLC1) signaling is the key pathway and tested this in trkBPLC/PLC
mice carrying amutation (Y816F) that uncouples TrkB from PLC1. Biochemical measures revealed activation of both TrkB and PLC1
in hippocampi in the pilocarpine and kindling models in wild-type mice. PLC1 activation was decreased in hippocampi isolated from
trkBPLC/PLC compared with control mice. Epileptogenesis assessed by development of kindling was inhibited in trkBPLC/PLC compared
with control mice. Long-term potentiation of the mossy fiber-CA3 pyramid synapse was impaired in slices of trkBPLC/PLC mice. We
conclude that TrkB-dependent activation of PLC1 signaling is an important molecular mechanism of limbic epileptogenesis. Elucidat-
ing signaling pathways activated by a cell membrane receptor in animal models of CNS disorders promises to reveal novel targets for
specific and effective therapeutic intervention.
Introduction
Understanding the mechanisms of limbic epileptogenesis in cel-
lular and molecular terms may lead to novel and specific thera-
pies aimed at preventing onset and/or progression of this
disorder. Extensive experimental evidence supports the assertion
that the neurotrophin, BDNF, promotes limbic epileptogenesis
by activation of its cognate receptor, TrkB. Expression of BDNF is
dramatically increased following a seizure in multiple animal
models (Ernfors et al., 1991; Isackson et al., 1991; Springer et al.,
1994). BDNF mRNA (Murray et al., 2000) and protein content
(Takahashi et al., 1999) are also increased in the hippocampus of
humans with temporal lobe epilepsy. Enhanced activation of
TrkB has been identified in multiple models of limbic epilepsy
(Binder et al., 1999; He et al., 2002; Danzer et al., 2004). Admin-
istration of BDNF and transgenic overexpression of BDNF en-
hance limbic epileptogenesis (Croll et al., 1999; Xu et al., 2004).
Striking impairments of epileptogenesis in the kindling model
were identified inmice carrying only a singleBDNF allele (Kokaia
et al., 1995), while epileptogenesis was eliminated altogether in
mice with a conditional deletion of TrkB in the CNS (He et al.,
2004).
Insight into the signaling pathways by which TrkB activation
promotes limbic epileptogenesis in vivomay provide clues to the
underlying cellular mechanisms as well as novel targets for ther-
apy. BDNF binding to TrkB results in receptor dimerization,
enhanced activity of the TrkB tyrosine kinase which results in
phosphorylation of Y515 and Y816 in the intracellular domain of
TrkB, thereby creating docking sites for adaptor proteins Shc and
PLC1 respectively. Both Shc and PLC1 are phosphorylated by
TrkB, thereby initiating Shc/Ras/MAP kinase and PLC1 signal-
ing respectively. Because epileptogenesis was similar in controls
and trkBSHC/SHC mutant mice (He at al., 2002), we hypothesized
that PLC1 signaling was activated during epileptogenesis in a
TrkB-dependent manner and that this activation promotes lim-
bic epileptogenesis. Substitution of phenylalanine for tyrosine at
residue 816 of TrkB (pY816 TrkB) in the trkBPLC/PLC mice selec-
tively eliminates binding and phosphorylation of PLC1 by TrkB
(Minichiello et al., 2002), thereby permitting study of functional
consequences of TrkB-mediated activation of PLC1 in vivo.
Materials andMethods
Mice. Animals were handled according to National Institutes of Health
Guide for the Care and Use of Laboratory Animals and approved by
Duke University Animal Care and Welfare Committee.
TrkBPLC/PLC mutant mice in a C57BL/6-129 background were gener-
ated by cDNA knockin approach as described previously (Minichiello et
al., 2002). In brief, PCR-based site-directed mutagenesis was used on
mouse TrkB cDNA to induce a single point mutation (A to T position
2958) that resulted in substituting phenylalanine for tyrosine 816
(Y816F), thereby disrupting the binding of PLC1. The mutant TrkB
cDNA (TrkBPLC) and control wild-type (WT) TrkB cDNA (TrkBWT)
were knocked into the juxtamembrane exon of the mouse trkB gene.
Wild-type (/), homozygous mutant trkB (trkBPLC/PLC) and WT
knockin trkB (trkBWT/WT) mice were used in this study. In addition,
trkBSHC/SHCmutantmice were used in one experiment. trkBSHC/SHCmu-
tant mice were generated as described previously (Minichiello et al.,
1998). In brief, PCR-aided mutagenesis was used to introduce a single
point mutation (A to T, position 2055) in the trkB receptor that substi-
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tuted phenylalanine for tyrosine 515 (Y515F). Nonphosphorylatable
F515 disrupted the binding of adaptor protein Shc to trkB and abolished
Shc site-mediated downstream signaling events.
The genotype of each animal was assessed twice using PCR of genomic
DNA isolated from tails (before and after experiments) as previously
described (He et al., 2002). In addition to PCR, the genotype of all mice
used in the kindling experiments was confirmed by sequencing.
Pilocarpine-induced status epilepticus. A single intraperitoneal (i.p.)
injection of pilocarpine, a muscarinic cholinergic agonist, was adminis-
tered to induce status epilepticus (SE). To minimize peripheral cholin-
ergic effects, male and female C57BL/6 mice of age 2–3 months were
treated with N-methyl scopolamine nitrate (1 mg/kg, i.p.) (Sigma). Fif-
teen minutes later, either pilocarpine (375 mg/kg) (Sigma) or vehicle
(normal saline) was injected i.p. and mice were observed for the appear-
ance of seizure activity and onset of SE for the next 3–4 h. Seizures were
classified according to Racine (1972) with slightmodifications (Borges et
al., 2003). Status epilepticus was defined as occasional or frequent myo-
clonic jerks, partial-or whole-body clonus, shivering, loss of posture, and
/or rearing and falling that was not interrupted by periods of normal
behavior. After 3 h of continuous seizure activity, diazepam (10 mg/kg,
i.p.) (Hospira) was administered to terminate SE. Pilocarpine-treated
animals that failed to exhibit SE or did not survive SEwere excluded from
the study. Unless specified otherwise, both pilocarpine- and saline-
treated mice were decapitated 6 h after the onset of SE for biochemical
and immunohistochemical experiments.
To ascertain that pilocarpine-induced status epilepticus assessed by
behavioral measures was associated with hippocampal electrographic
seizure, a pilot experiment was performed in which a bipolar recording
electrode was placed in the right dorsal hippocampus using stereotaxic
guidance (2.0 mm posterior and 1.6 mm lateral to bregma and 1.5 mm
below dura) under pentobarbital anesthesia. One week thereafter ani-
mals were given N-methyl scopolamine and pilocarpine as described in
the preceding paragraph; 3 h after onset, status epilepticus was termi-
nated by diazepam. EEG recordings revealed electrographic seizure activity
in hippocampus in all animals (3/, 2 trkBWT/WT, and 3 trkBPLC/PLC), the
durationofwhichcorrespondedto thedurationof statusepilepticusassessed
by behavioral measures (data not shown). Behavioral measures alone were
used toassess statusepilepticus for the remainderof theexperimentswith the
pilocarpine model.
Surgery and kindling. Twelve /, 12 trkBWT/WT and 10 trkBPLC/PLC
mice were included in the kindling experiment. Procedures for surgery
and kindling were performed as described previously (He et al., 2002,
2004) by an individual blinded to genotype of the animals. Briefly, under
pentobarbital (60 mg/kg) (Ovation) anesthesia, a bipolar electrode used
for stimulation and recording was stereotactically implanted in the right
amygdala. Following a postoperative recovery period of 2 weeks, the
electrographic seizure threshold (EST) in the amygdala was determined
and stimulations at the intensity of the EST were subsequently adminis-
tered twice daily, 5 d per week as described previously (He et al., 2002,
2004). The behavioral manifestations of seizures were classified accord-
ing to a modification of the description of Racine (1972) as described
previously. Mice were stimulated until fully kindled as defined by the
occurrence of 3 consecutive seizures of class 4 or greater. Unstimulated
control animals of each genotype underwent surgical implantation of an
electrode in amygdala and were handled identically but were not stimu-
lated. Six hours after the last stimulation, the stimulated and unstimu-
lated mice were decapitated for further study. Accuracy of electrode
placements were verified by histological analysis and only animals
with correct electrode placement in the amygdala were included in the
statistical analysis for kindling experiment. All kindling data are pre-
sented as mean  SEM and analyzed by one-way ANOVA with post
hoc Bonferroni’s test.
Biochemistry. Following decapitation, the mouse head was quickly
dipped into liquid nitrogen for 4 s to rapidly cool the brain. The hip-
pocampi were rapidly dissected on ice and homogenized in lysis buffer
[20 mM Tris, pH 8.0, 137 mM NaCl, 1% NP40, 10% glycerol, 1 mM
sodium orthovanadate (NaOV), 1 mM phenylmethylsulfonylfuoride
(PMSF), and 1 Complete Mini protease inhibitor tablet (Mini,
Roche)/10 ml]. The supernatant was saved following centrifugation at
16,000  g for 10 min, aliquoted and stored at 80°C for further bio-
chemical analysis.
In experiments studying a synaptosomal membrane fraction, hip-
pocampi were homogenized in an isotonic sucrose buffer (0.32 M su-
crose, 4 mM HEPES, 1 mM NaOV, 1 mM PMSF, and 1 Mini tablet/10 ml,
pH 7.4), centrifuged at 325  g for 10 min at 4°C, and the supernatant
was collected and centrifuged at 16,000 g for 15min to provide a crude
synaptosomal pellet. Crude synaptosomes underwent osmotic shock by
addition of ice-cold deionized H2O and rapidly returned to osmotic
balance with 1 M HEPES pH 7.4; following centrifugation at 16,000 g
for 30 min, the pellet consisting of an enriched synaptosomal membrane
fraction was collected. BCA kit (Thermo Scientific) was used to deter-
mine the protein concentration.
Western blotting was performed to analyze phosphorylated and non-
phosphorylated TrkB and PLC1 using procedures as described previ-
ously (He et al., 2004; Huang et al., 2008). The following antibodies were
used in these experiments: p-Trk (Y816) (a gift from Dr. Moses Chao,
New York University, New York, NY); p-PLC1 (Y783) (Biosource);
TrkB (BD Biosciences); PLC1 (Cell Signaling Technology); -actin
(Sigma). The results fromWestern blotting were quantified by a method
described previously (Huang et al., 2008). Briefly, the immunoreactivity
of individual band onWestern blots was measured by ImageQuant soft-
ware and normalized to TrkB or -actin content; similar results were
obtained with the two methods. Student’s t test and one-way ANOVA
were used for statistical analyses. Results are presented as mean SEM
for the designated number of experiments.
P-Trk immunohistochemistry. P-Trk immunohistochemistry was per-
formedusing the protocol described previously (Danzer andMcNamara,
2004; Danzer et al., 2010). Briefly, under pentobarbital anesthesia (200
mg/kg), mice were perfused with 4% paraformaldehyde in PBS and the
brains were removed, postfixed and cryoprotected. Forty micrometer
coronal sections were cut and used for immunofluorescent staining. Af-
ter 1 h incubation with blocking solution (5% NGS, 0.5% NP40 in PBS
buffer with 1 mM NaOV), pY816 antibody was applied to floating sec-
tions overnight at 4°C. Alexa Fluor 594 goat anti-rabbit secondary anti-
body (Invitrogen) was used to visualize the immunofluorescent staining.
The sections from experimental and control animals of different geno-
types were processed simultaneously in the same incubation plates using
the identical solutions and protocol so that valid comparisons could be
made. Images were captured and quantified using a Leica TCS SL confo-
cal system. Immunoreactivity over the corpus callosum was sampled in
each section as internal control because of its low immunoreactivity. In
addition values were collected from a square of fixed size over CA1 stra-
tum oriens, CA1 stratum lacunosum-moleculare, and CA3a stratum
lucidum (supplemental Fig. 1b, available at www.jneurosci.org as supple-
mental material) and presented as percentage of value of corpus callo-
sum. The specificity of pY816 antibody for TrkB pY816 was verified by
the reductions of immunoreactivity in stratum lucidum of trkBPLC/PLC
compared with control mice (supplemental Fig. 1a, available at www.
jneurosci.org as supplemental material). All results from experimental
mice and their controls were analyzed by Student’s t test.
Hippocampal slice preparation and electrophysiology. Mice (postnatal
day 28–42) were anesthetized with pentobarbital and decapitated. The
brain was quickly removed and placed in ice-cold buffer containing the
following (in mM): 110 sucrose, 60 NaCl, 3 KCl, 1.25 NaH2PO4, 28
NaHCO3, 0.5 CaCl2, 7.0 MgCl2, and 5 dextrose, saturated with 95% O2
plus 5% CO2, pH 7.4. Following dissection of hippocampi, transverse
slices (400 m in thickness) were cut with a vibratome and incubated in
oxygenated artificial CSF (ACSF) containing the following (in mM): 124
NaCl, 1.75KCl, 1.25KH2PO4, 26NaHCO3, 2.4 CaCl2, 1.3MgCl2, and 10 dex-
troseforat least1hat32–34°beforerecording.Thesliceswerethentransferredto
a recording chambermounted onZeissAxioskopuprightmicroscope.
The following criteria were applied to be considered a mossy fiber
excitatory postsynaptic field potentials (fEPSP): (1) the ratio for
paired pulse facilitation (PPF) at 60 ms interval was 1.75 or greater;
(2) frequency facilitation at 20 Hz was 2.0 or greater as determined
by the ratio of the amplitude of the response to the third pulse com-
pared with the first pulse (Toth et al., 2000); and (3) application of the
Group II metabotropic glutamate receptor (mGluR) II agonist 2-(2,
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3-dicarboxycyclopropy) glycine (DCG-IV) 1
M at the end of the experiment reduced the
amplitude of the evoked fEPSP by at least 70%.
Addition of picrotoxin, which blocks feedfor-
ward inhibition of CA3 pyramids evoked by
mossy fiber activation of interneurons in stra-
tum lucidum, did not modify the latency, am-
plitude, or waveform of the mossy fiber (mf)-
CA3 pyramid fEPSP. The mossy fiber-CA3
pyramid fEPSPs were induced by a bipolar
tungsten stimulating electrode placed at the
junction of the granule cell layer and hilus near
the midpoint of the suprapyramidal blade of
the dentate. Extracellular recordings were ob-
tained with a glass micropipette filled with 2 M
NaCl, 2–6M resistance placed in stratum lu-
cidum near the junction of CA3a and CA3b.
An input-output curve was obtained by hilar
stimulation (0.2 ms square pulses delivered at
0.03 Hz) with a Digitmer constant current stim-
ulator (DS3,DigitimerLtd.).A stimulus intensity
sufficient to induce a fEPSP amplitude approxi-
mating 30% of the maximum amplitude was
used for these experiments. D, L-APV (100 M)
was included in perfusion solution to eliminate
contamination of associational-commissural af-
ferents (Zalutsky and Nicoll, 1990). LTP was
induced by applying a total of 4 trains of high-
frequency stimulation (HFS) (each train con-
sisting of 0.2 ms pulses at 100 Hz for 1 s and
intensity sufficient to induce maximum fEPSP
amplitude and intertrain interval of 10 s). To
assure objectivity, the individual performing
all experiments with wild-type and mutant
mice was blinded as to genotype.
For the LTP experiment, the amplitude of fEPSPs was measured and
LTP was plotted as mean percentage change in the fEPSP amplitude
50–60 min after HFS relative to the 10 min of fEPSP amplitude imme-
diately preceding the HFS. The numbers listed in the figure legends and
text refer to the number of animals. Results are typically obtained and
averaged from at least two slices from each animal and the average value
is presented as a single value for each animal. Data were collected from
slices at room temperature using aMulti 700A amplifier and pClamp 9.2
software (Molecular Devices). The synaptic responses were filtered at 2
kHz and digitized at 5 kHz. All data were presented as mean SEM and
analyzed by Student’s t test with Excel (Microsoft) and Prism (GraphPad
Software) software.
Results
Biochemical study of TrkB and PLC signaling during
limbic epileptogenesis
Induction of continuous seizure activity for a couple h by system-
ically administered pilocarpine is followed by emergence of spon-
taneous recurrent seizures arising weeks thereafter, thereby
recapitulating some features of temporal lobe epilepsy (TLE) in
humans (Lemos and Cavalheiro, 1995; Klitgaard et al., 2002). To
test whether TrkB and PLC1 underwent activation in the pilo-
carpine model, Western blots were prepared from hippocampal
homogenates isolated from wild-type (/) mice 6 h following
the onset of status epilepticus induced by injection of pilocarpine.
Status epilepticus was associated with increased tyrosine phos-
phorylation of Trk as evidenced by increased immunoreactivity
of a 145 kDa band detected by an antibody specific to pY816 Trk
(Fig. 1a, top). Note that the increased size of the pY816 Trk band
in the status epilepticus treatment (Fig. 1a, top) compared with
vehicle is similar to that observed by Iwakura et al. (2008), (see
Fig. 4) upon BDNF treatment of heterologous cells expressing
TrkB using the same antibody; the increased size of the band
likely reflects TrkBmolecules phosphorylated to different extents
resulting in small differences of migration within the SDS gel. No
significant increase of TrkB content was detected (Fig. 1a, top).
Quantitative analysis ofWestern blot data 6 h after onset of status
epilepticus revealed a 2.3-fold increase of pY816 relative to TrkB
in the pilocarpine-treated group (n 7) compared with normal
saline (NS) controls (n  6) ( p  0.05), Student’s t test. The
increased pY816 immunoreactivity was time dependent as re-
vealed by modest increases evident at 30 min and 3 h, more
marked increases at 6–24 h, and a return to baseline values 1week
later (Fig. 1a, bottom). The 3.5-fold increase of pY816 Trk rela-
tive toTrkB in 6 h group (a separate group from thatwith 2.3-fold
increase described above) is significantly higher than in NS con-
trols ( p 0.001, one-way ANOVA).
Because phosphorylation of Y816 of TrkB activates PLC1
signaling in vitro in cultured neurons and recombinant systems,
the increased pY816 immunoreactivity predicted enhanced acti-
vation of PLC1 itself. Consistent with this prediction, increased
immunoreactivity of a 150 kDa band detected by an antibody
specific to pY783 PLC1 was evident in hippocampal homoge-
nates isolated 6 h after onset of pilocarpine-induced status epi-
lepticus (Fig. 1b, top). No change in content of PLC1 itself was
found (Fig. 1b). Quantitative analysis of Western blot data 6 h
after onset of status epilepticus revealed a 1.8-fold increase of
pY783 relative to PLC1 in pilo (n 7) compared with NS con-
trols (n  6) ( p  0.01), Student’s t test. The increased pY783
immunoreactivity was also time dependent as revealed bymodest
increases evident at 30 min and 3 h, more marked increases at
6–12 h, and a return to baseline values 1 week later (Fig. 1b,
bottom). The 2.7- and 3.4-fold increases of pY783 PLC1 relative
Figure 1. TrkB-PLC1 signaling is increased in the pilocarpine (pilo)model. a, Top, RepresentativeWestern blot of pY816 TrkB
and TrkB in hippocampal homogenate isolated 6 h after onset of status epilepticus. Bottom, Quantitative analysis of Western blot
of pY816 TrkB at multiple times (30 min, 3 h, 6 h, 12 h, 24 h and 1 week) after onset of pilo-induced status epilepticus. The-fold
increase of pY816 Trk relative to TrkB in 6 h group is significantly higher than in NS controls ( p 0.001). Western blots were
quantified and presented as mean SEM of fold increase of pY816 relative to TrkB in pilo mice (n 4 for each time point)
comparedwith NS controls (n 4). Note that different groups of animals were studied at 6 h after pilo in bottompanel compared
with top panel. b, Top, Representative Western blot of pY783 PLC1 and PLC1 in hippocampal homogenate isolated 6 h after
onset of status epilepticus. Bottom, Quantitative analysis ofWestern blot of pY783 relative to PLC1 immunoreactivity atmultiple
times after onset of pilo-induced status epilepticus. The fold increases of pY783PLC1 relative toPLC1 in 6h ( p0.01) and12h
( p 0.001) groups are significantly higher than in NS controls. Data are presented as mean SEM of fold increase of pY783
relative to PLC1 in pilomice (n4 for each timepoint) comparedwithNS controls (n4). Note that different groups of animals
were studied at 6 h after pilo in the bottom panel compared with the top panel.
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to PLC1 at 6 and 12 h respectively are significantly higher in the
pilo-treated group compared with NS controls (6 h vs NS, p 
0.01; 12 h vs NS, p 0.001, one-way ANOVA).
To test whether TrkB and PLC signaling were activated in a
distinct model of limbic epileptogenesis, Western blots were pre-
pared from hippocampal homogenates isolated from wild-type
mice 6 h following a class 4/5 kindled seizure evoked by amygdala
stimulation. The kindled seizure also resulted in increased pY816
Trk immunoreactivity (Fig. 2a). No significant increase of TrkB
content was detected (Fig. 2a). Quantitative analyses of Western
blots revealed a 1.8-fold increase of pY816 relative to TrkB in
mice killed 6 h after a class 4/5 kindled seizure (K) (n 4) com-
pared with unstimulated controls (C) (n  3) ( p  0.05), Stu-
dent’s t test. Consistent with this increase of pY816 Trk
immunoreactivity, a kindled seizure also induced increased ty-
rosine phosphorylation of PLC1 itself 6 h afterward as evi-
denced by increased pY783 PLC1 immunoreactivity (Fig. 2b).
No change in content of PLC1 itself was detected (Fig. 2b). The
1.9-fold increase of pY783 relative to PLC1 in K (n  4) com-
pared with C (n 3) was significant ( p 0.05), Student’s t test.
The correlation of increased pY816 Trk and pY783 PLC1
immunoreactivity at 6 h after seizures in two distinct models of
limbic epilepsy together with similarity of time course in the
pilocarpine model provided circumstan-
tial evidence that the enhanced PLC1 ac-
tivation induced by status epilepticus was
a consequence of TrkB activation. The
availability of trkBPLC/PLC mice in which
substitution of phenylalanine for tyrosine
at residue 816 of TrkB selectively elimi-
nates binding and phosphorylation of
PLC1 by TrkB enabled us to test directly
in vivo whether activation of PLC1 dur-
ing status epilepticus was a consequence
of TrkB activation. We first examined
pY816 Trk immunoreactivity in synaptic
membranes isolated from trkBWT/WT and
trkBPLC/PLC mice isolated 6 h following
status epilepticus. Consistent with find-
ings in Figure 1, status epilepticus was
associated with increased pY816 Trk im-
munoreactivity in hippocampal synaptic
membranes isolated from trkBWT/WTmice
(Fig. 3, top). Quantification of pY816 im-
munoreactivity revealed a 1.6-fold in-
crease in trkBWT/WT animals killed 6 h
after status epilepticus (Fig. 3a, bottom,
n 3, p 0.001). Analysis of pY816 im-
munoreactivity in trkBPLC/PLC following
treatment with normal saline revealed a
40% reduction compared with trkBWT/WT
animals (Fig. 3a, n  3, p  0.05), dem-
onstrating that phosphorylation of pY816
of TrkB itself contributes to pY816 immu-
noreactivity measured under basal condi-
tions. Likewise following status epilepticus,
the pY816 immunoreactivity in trk-
BWT/WT exceeded that in trkBPLC/PLC mice
by 1.7-fold (Fig. 3a, n  3, p  0.001),
demonstrating that the increased pY816
immunoreactivity following status epilep-
ticus is due mainly to phosphorylation of
TrkB. A small increase of pY816 immuno-
reactivity of 145 kDa band was evident following status epilepti-
cus in trkBPLC/PLC mice (Fig. 3a, n 3, p 0.05), suggesting the
possibility that status epilepticus may also result in increased
pY816 immunoreactivity of TrkC.
Next we asked whether the status epilepticus-induced activa-
tion of PLC1 was dependent upon TrkB activation, again prob-
ing Western blots of hippocampal synaptic membranes isolated
from trkBWT/WT and trkBPLC/PLC with an antibody specific to
pY783 PLC1. Increased pY783 PLC1 immunoreactivity was
evident following status epilepticus in trkBWT/WT mice (Fig. 3b,
top). Quantification of the pY783 immunoreactivity revealed a
2.0-fold increase in trkBWT/WT animals killed 6 h after status epi-
lepticus (Fig. 3b, bottom, n  3, p  0.051). Analysis of pY783
PLC1 immunoreactivity in trkBPLC/PLC following treatment
with normal saline revealed a 38% reduction compared with
trkBWT/WT animals which was not statistically significant (Fig. 3b,
n  3, p  0.05). Following status epilepticus, pY783 PLC1
immunoreactivity in trkBWT/WT exceeded that in trkBPLC/PLC
mice by 1.9-fold (Fig. 3b, n 3, p 0.05), demonstrating that the
status epilepticus-induced increase of pY783 PLC1 is due pre-
dominantly to TrkB activation. The small absolute increase of
pY783 PLC1 immunoreactivity in trkBPLC/PLC mice following
Figure 2. TrkB-PLC1 signaling is increased in the kindling model. a, Representative Western blot of pY816 TrkB and TrkB in
hippocampal homogenate isolated 6 h after last stimulation-induced class 4/5 kindled seizure. b, Representative Western blot of
pY783 PLC1 and PLC1 in hippocampal homogenate isolated 6 h after last Class 4/5 kindled seizure.
Figure 3. Effect of trkBPLC/PLCmutation on TrkB-PLC signaling. a, Top, RepresentativeWestern blot of pY816 TrkB and TrkB in
hippocampal synaptosomal membranes isolated 6 h after onset of pilo-induced status epilepticus from trkBPLC/PLC or trkBWT/WT
mice. Bottom, Quantitative analysis of Western blot. The fold increases of pY816 to TrkB from 3 experiments in trkBPLC/PLC were
comparedwith that from trkBWT/WTmice. One-wayANOVA ( p 0.001).b, Top, RepresentativeWestern blot of pY783 PLC1 and
PLC1 in hippocampal synaptosomal membranes isolated 6 h after onset of pilo-induced status epilepticus from trkBPLC/PLC or
trkBWT/WTmice. Bottom,Quantitative analysis ofWesternblot. The fold increases of p-PLC1 relative to PLC1 from3experiments
in trkBPLC/PLCwere compared with that from trkBWT/WTmice. Data are presented as means SEM, one-way ANOVA ( p 0.01).
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status epilepticus (Fig. 3b, n  3, p  0.05) was not statistically
significant.
Effect of limiting TrkB-dependent PLC1 signaling on limbic
epileptogenesis in vivo
The evidence of enhanced TrkB-dependent activation of PLC1
signaling during status epilepticus together with previous evi-
dence of a requirement for TrkB for induction of epileptogenesis
in the kindling model (He et al., 2004) raised the question as to
whether TrkB activation of PLC1 signaling is critical to epilep-
togenesis. To address this question, we examined epileptogenesis
in the kindling model in trkBPLC/PLC mice that selectively pre-
vents activation of the PLC1 signaling pathway by TrkB.
trkBPLC/PLC mice exhibited a marked inhibition of the rate of
kindling development as evident in the increased number of
stimulations required to elicit behavioral seizures compared with
both/ and trkBWT/WTmice (Fig. 4, top). The number of stim-
ulations required to evoke a limbic seizure termed class 1 or 2
(Fig. 4, bottom) was increased by 3-fold in trkBPLC/PLC mice
(9.5 2.5, n 10) compared with either of two controls (/
2.5 0.5, n 12, p 0.01) (trkBWT/WT, 2.8 0.4, n 12, p
0.01). Likewise the number of stimulations required to evoke the
third consecutive clonic tonic seizure (class 4 or greater) (Fig. 4,
bottom) was increased by 2-fold in trkBPLC/PLC (26.2  4.6)
compared with either of two controls (/ 12.0 0.9, p 0.01)
or trkBWT/WT (11.1 1.0, p 0.001). By contrast, no significant
differencewas evident in the electrographic seizure duration dur-
ing kindling development among 3 genotypes. Likewise no sig-
nificant differences were detected in the current required to
evoke an initial electrographic seizure duration in the three
groups (/ 150.0  27.3 A; trkBWT/WT 172.7  24.5 A;
trkBPLC/PLC 128  14.1 A; p  0.05). Together, these results
demonstrate that selectively limiting activation of PLC signaling
by TrkBmarkedly inhibits epileptogenesis in the kindlingmodel.
Immunohistochemical localization of pY816 Trk
Immunoreactivity in limbic epileptogenesis
The pivotal role of TrkB-dependent PLC1 signaling in epilepto-
genesis in the kindling model raised the question as to potential
cellular consequences of the enhanced activation of TrkB and
PLC1 that might contribute to epileptogenesis. Insight into the
anatomic locale of the enhanced TrkB activation would provide a
valuable clue as to the nature and locale of potential cellular
mechanisms. Our previous results provided immunohistochem-
ical evidence that TrkB receptors undergo increased phosphory-
lation during epileptogenesis in a spatially specific pattern in the
hippocampus, that is, increased p-Trk (pY515) was evident in the
mossy fiber pathway inmultiplemodels (Binder et al., 1999;He et
al., 2002). That said, the anatomic locale of enhanced pY816 Trk
immunoreactivity detected by Western blotting in the pilo-
carpine and kindling models is unknown. To address this ques-
tion, we performed pY816 immunohistochemistry in these
models.
The immunohistochemical pattern in sections prepared from
WT mice killed 6 h after onset of status epilepticus revealed in-
creased pY816 Trk immunoreactivity in the stratum lucidum
of CA3a bilaterally (only one hippocampus shown) in all brain
sections examined (Fig. 5a, top); no overt changes of p-Trk
immunoreactivity were noted elsewhere in the hippocampus.
Quantification revealed a 1.7-fold increase of pY816 immuno-
reactivity in CA3a stratum lucidum in pilocarpine (n  6)
compared with normal saline (n  5)-treated animals ( p 
0.05) (Fig. 5a, bottom). By contrast, no significant changes
were detected in stratum oriens or lacunosum-moleculare of
CA1. Like the pilocarpine model, increased pY816 Trk immu-
noreactivity was detected in the mossy fiber pathway of hip-
pocampus bilaterally of animals killed 6 h after the last class
4/5 seizure evoked by amygdala stimulation in the kindling
model compared with sham-stimulated controls (Fig. 5b,
top). Quantification revealed 2.6-fold increase of pY816 im-
munoreactivity in CA3a stratum lucidum in kindled (n  4)
compared with control group (n  3) ( p  0.05) (Fig. 5b,
bottom). By contrast, no significant changes were detected in
stratum oriens or lacunosum-moleculare of CA1.
Inhibition of LTP of mossy fiber-CA3 pyramid synapse in
trkBPLC/PLCmice
The anatomic localization of the increased pY816 Trk immuno-
reactivity to the mossy fiber pathway directed study of potential
cellular consequences of TrkB activation to this locale. One con-
sequence of TrkB activation in this locale that might promote
limbic epileptogenesis is development of LTP of the excitatory
synapse of mf axons of dentate granule cells with CA3 pyramidal
cells. Our previous work demonstrated that inhibiting TrkB ki-
nase activity eliminated LTP of this synapse induced by HFS of
the dentate granule cells (Huang et al., 2008). To determine
whether TrkB signaling through PLC in particular is required
for LTP of this synapse, the effects ofHFS of themf on the efficacy
Figure 4. Top, Kindling development is inhibited in trkBPLC/PLC mutants. Kindling develop-
ment is presented as behavioral seizure class ( y-axis). Stimulation number (x-axis) refers to the
number of stimulations that evoked an electrographic seizure with duration of at least 5 s.
Bottom, number of stimulations required to reach different seizure classes inwild-type (/)
(n 12), trkBWT/WT (n 12), and trkBPLC/PLC (n 10). Fully kindled stage is defined by the
occurrence of three consecutive seizures of class 4 or 5. For the number reaching first class1 or 2,
/ versus trkBPLC/PLC, p 0.01; trkBWT/WT versus trkBPLC/PLC, p 0.01. For the number
reaching first class 4 or 5,/ versus trkBPLC/PLC, p 0.05; trkBWT/WT versus trkBPLC/PLC, p
0.01. For the number reaching fully kindled stage,/ versus trkBPLC/PLC, p 0.01; trkBWT/WT
versus trkBPLC/PLC,p0.001.All data arepresentedasmeanSEM;one-wayANOVAwithpost
hoc Bonferroni’s test.
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of this synapse were compared in trkBPLC/PLC and control mice.
Significant ( p  0.01) impairments of HFS-induced LTP of the
mf-CA3 pyramid synapse were detected in slices isolated from
trkBPLC/PLC (115  3%, n  7) compared with WT (155  9%,
n  8) or trkBWT/WT (148  4%, n  7) control mice (Fig. 6).
Importantly, no differences in basal synaptic transmission were
detected between trkBPLC/PLC and control mice as evident in part
by similar ratios of paired pulse facilitation of the fEPSP in the
three groups (PPF: /, 2.56  0.5, n  5; trkBPLC/PLC, 1.83 
0.3, n 5, p 0.05, t test and trkBWT/WT 1.95 0.3, n 5, p
0.05, t test). Moreover, the impairment of mf-LTP was specific to
the PLC1 signaling pathway because nodifferences in LTPof the
mf-CA3pyramid synapsewere detected in trkBSHC/SHC compared
with WT control mice (/, 144  7%, n  6; trkBSHC/SHC,
145 7%, n 5, p 0.05, t test). Together, these data demon-
strate that TrkB-dependent signaling through the PLC1 but not
the Shc pathway is required for LTP of the mf-CA3 pyramid
synapse.
Discussion
We hypothesized that the neurotrophin receptor, TrkB, promotes
limbic epileptogenesisbyactivationof thePLC1 signalingpathway.
We used biochemical, immunohistochemical, and electrophys-
iological studies of trkBWT/WT and trkBPLC/PLC mice to test this
hypothesis. Four principal findings
emerged. (1) Time-dependent increases
of both pY816 Trk and pY783 PLC1 im-
munoreactivity were detected in hip-
pocampi of WT mice in the pilocarpine
and kindling models. The enhanced
pY783 PLC1 immunoreactivity in the
pilocarpine model was decreased in hip-
pocampi isolated from trkBPLC/PLC mice.
(2) Limbic epileptogenesis asmeasured by
development of kindling was markedly
inhibited in trkBPLC/PLC mice. (3) The en-
hanced pY816 Trk immunoreactivity in
WT mice was selectively localized to the
mossy fiber pathway within hippocampus
in these models. (4) LTP of the mossy
fiber-CA3 pyramid synapse was impaired
in slices of trkBPLC/PLCmice. We conclude
that activation of pY783 PLC1 is due
mainly to TrkB activation in these models
and that TrkB-induced PLC1 signaling
promotes limbic epileptogenesis.
The spatial and temporal patterns of
TrkB activation are notable. While the
precise identity of the endogenous li-
gand(s) promoting TrkB activation in
these models is uncertain, the prototypic
agonist of TrkB, BDNF, is a leading can-
didate. Yet persistence of increased pY515
TrkB following seizures in BDNF condi-
tional knock-outmice (He et al., 2004) led
to the discovery that the divalent cation,
zinc, can transactivate TrkB by a BDNF
independent mechanism in vitro (Huang
et al., 2008). The localization of increased
pY816 TrkB immunoreactivity exclu-
sively to stratum lucidum is puzzling be-
cause both BDNF and zinc are thought to
reside in synaptic vesicles of axons of CA3
andCA1 pyramids and to be released dur-
ing hippocampal seizures; this should result in increased pY816
TrkB in strata oriens and radiatum of CA3 and CA1 yet no
increase of pY816 was found in these regions (Fig. 5). The
localization of increased pY816 TrkB immunoreactivity to
stratum lucidum correlates with the highest concentrations of
BDNF protein and vesicular zinc within hippocampus and fore-
brain (Yan et al., 1997; Cole TB et al., 1999; Frederickson et al.,
2005). Thus low concentrations of BDNF and zinc together with
limited sensitivity of the immunohistochemical method likely
contribute to our inability to find increases in hippocampal re-
gions apart from stratum lucidum. We suspect that similar fac-
tors contribute to an additional unexpected result, namely the
absence of increased pY816 TrkB immunoreactivity in Western
blots 30 min or 3 h following onset of status epilepticus (Fig. 1).
The lack of increase at 30 min and 3 h is unexpected for several
reasons: (1) both endogenous BDNF and zinc are released in an
activity-dependent fashion (Balkowiec and Katz, 2002; Qian and
Noebels, 2005; Matsumoto et al., 2008); (2) the synchronous,
high-frequency firing of populations of hippocampal neurons
(Labiner et al., 1993; Alexander et al., 2009) almost certainly trig-
gers synaptic release of both BDNF and zinc during the seizures;
(3) application of either BDNF or zinc to cultured neurons trig-
gers striking activation of TrkB within 5–15 min (Huang et al.,
Figure 5. Immunohistochemical localization of pY816 TrkB Immunoreactivity in limbic epileptogenesis. a, pY816 immunore-
activity is increased in pilomodel. Top, representative images in lowmagnification (Lowmag) and highmagnification (Highmag)
fromstratum lucidumof CA3a inhippocampusof pY816 immunoreactivity in sections prepared6hafter onset of status epilepticus.
Note that the increasedpY816 immunoreactivitywas foundmainly in themossy fiber pathwayasdenotedbyarrowheads. Bottom,
Quantitative analysis of pY816 immunoreactivity in hippocampal subregions of mice treated with NS or after 6 h of pilo-induced
status epilepticus (pilo). The pY816 immunoreactivity in CA3a stratum lucidum was increased 1.7 fold in pilo (n 6) compared
with NS (n 5)-treated mice ( p 0.05, Student’s t test). b, pY816 immunoreactivity is increased in the kindling model. Top,
Representative images in low magnification (Low mag) and high magnification (High mag) of pY816 TrkB immunoreactivity in
hippocampal sections prepared 6 h after last stimulation-induced class 4/5 kindled seizure. Note the increased pY816 immunore-
activity in the mossy fiber pathway as denoted by arrowheads. Bottom, quantitative analysis of pY816 immunoreactivity in
hippocampal subregions of kindled and controlmice. The pY816 immunoreactivity in CA3a stratum lucidumwas increased 2.6 fold
in kindled (n 4) comparedwith control group (n 3) ( p 0.05). Data are presented asmeans SEM, Student’s t test. Scale
bar, 300m in lowmagnification; 50m in high magnification.
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2008); (4) impairments of LTP in slices from BDNF knock-out
mice or with zinc chelators provide functional evidence of TrkB
activation as early as 15 min following high-frequency stimula-
tion (Korte et al., 1995; Patterson et al., 1996; Huang et al., 2008;
Matsumoto et al., 2008). Collectively, this suggests that TrkB is
activated at 30 min and 3 h following onset of status epilepticus
yet escapes detection. Perhaps higher concentrations of BDNF
mediated by seizure-evoked increases of transcription and trans-
lation results in a greater and more readily detectable activation
of TrkB at later time points, a suggestion consistent with in-
creased BDNFmRNAandprotein 3–7 h after onset of hippocam-
pal seizures (Ernfors et al., 1991; Isackson et al., 1991; Nawa et al.,
1995; Yan et al., 1997). If BDNF activates TrkB at these later time
points inWTanimals, then compensatory increases of other neu-
rotrophins (e.g., NT-3) and/or zinc may mediate the late in-
creases of TrkB activation detected in conditional BDNF knock-
out mice (He et al.,2004). That said, the latency of several hours
between seizure onset and detectable increases of TrkB activation
may provide a therapeutic window within which to intervene
with an inhibitor to limit progressive severity of epilepsy.
Themarked inhibitionof developmentof kindlingof trkBPLC/PLC
mice establishes a causal role for TrkB-dependent PLC1 signal-
ing in limbic epileptogenesis in vivo. Given the enormous diver-
sity of cell surface receptors presumably undergoing activation
during an event as complex as a seizure (McNamara et al., 2006),
the activation of PLC1 almost exclusively by TrkB (Fig. 3) is
remarkable. Also remarkable is the striking specificity of signal-
ing pathways downstream of TrkB with respect to the phenotype
of epileptogenesis. That is, increases of both pY515 and pY816
immunoreactivity in diverse models of limbic epileptogenesis
(Binder et al., 1999; He et al., 2004) suggest that TrkB activates
both Shc and PLC1 signaling. Yet in contrast to the marked
inhibition of development of kindling in trkBPLC/PLC mice, no
differences in development of kindling were detected between
WT and trkBSHC/SHC mice (He et al., 2002). Although inhibition
of kindling is marked in trkBPLC/PLCmice, the magnitude of inhi-
bition was less than reported previously with conditional trkB-
nulls in which trkB was recombined from CNS neurons by
crossing synapsin-crewith floxed trkBmice (He et al., 2004). No-
tably, the mutation of the trkBPLC/PLC is in the germline whereas
the onset of trkB recombination is delayed until late in embryonic
development in the synapsin-cre trkBFLOX/FLOX; perhaps perturb-
ing TrkB signaling earlier in the life of the trkBPLC/PLCmice com-
paredwith the conditional nullmutants facilitates emergence of a
compensatory mechanism that promotes epileptogenesis. The
residual immunoreactivity detected by the pY816 Trk antibody
migrating at 	145 kDa in SDS-PAGE (Fig. 3) of hippocampi of
trkBPLC/PLC mice likely represents p-TrkC; if so, this might be a
compensatory mechanism promoting epileptogenesis. Alterna-
tively, perhaps TrkB-mediated activation of the Shc pathway pro-
motes epileptogenesis in the absence but not presence of TrkB-
mediated activation of PLC1 signaling.
The inhibition of epileptogenesis in the trkBPLC/PLCmice pro-
vides clues to cellular mechanisms by which enhanced activation
of TrkB promotes limbic epileptogenesis. Both ex vivo and in vivo
studies of animal models suggest that LTP of excitatory synapses
between principal cells contributes to limbic epileptogenesis
(Sutula and Steward, 1987); potentiation of these synapses may
facilitate propagation of seizure activity through synaptically
coupled neuronal populations in the limbic system and beyond.
Evidence that the mf-CA3 pyramid synapse undergoes LTP in
vivo emerged in the kainic acid model of limbic epilepsy (Gous-
sakov et al., 2000). The requirement for TrkB-dependent PLC1
signaling for LTP of this synapse together with evidence of in-
creased pY816 immunoreactivity in themf pathway in sections ex
vivo from thesemodels suggests that TrkB-mediated activation of
PLC1 signaling in vivo may contribute to LTP of this synapse
during epileptogenesis. The fact that LTP of these synapses re-
mains intact in the trkBSHC/SHCmice is consistent with findings at
the Schaffer collateral-CA1 synapse (Minichiello et al., 2002;
Minichiello, 2009) and correlates with similar rates of kindling
development in trkBSHC/SHC and control mice (He et al., 2002).
Notably, enhanced excitability in models of epilepsy is often
accompanied and likely caused by both enhanced function of
excitatory synapses and impaired function of inhibitory synapses.
Might enhanced activation of PLC1 signaling by TrkB somehow
compromise inhibitory function and thereby contribute to the
increased excitability of limbic epilepsy? One interesting pos-
sibility is that enhanced TrkB-dependent activation of PLC1
signaling reduces expression of the K-Cl cotransporter, KCC2,
resulting in accumulation of [Cl]i and a shift of EGABA in a
depolarizing direction (Rivera et al., 2004). Collectively, study of
human epileptic tissue (Cohen et al., 2002;Huberfeld et al., 2007)
buttressed by study of diverse in vivo and in vitromodels (Rivera
et al., 2002, 2004; Woo et al., 2002; Pathak et al., 2007; Li et al.,
2008; Blaesse et al., 2009) advance reduced expression of KCC2
and resulting accumulation of [Cl]i as an important molecular
Figure 6. Mf-CA3 LTP is impaired in trkBPLC/PLC mutants. Hippocampal slices were isolated
from wild-type or mutant mice and mf-evoked fEPSPs were recorded. Graphs represent
mean SEMof the responses evoked comparedwith baseline. Traces of representative exper-
iments are shown above each graph. Top, HFS-inducedmf LTP is impaired in trkBPLC/PLCmutant
mice. Significant ( p 0.01) impairments of HFS-induced LTP of the mf-CA3 pyramid synapse
were detected in slices isolated from trkBPLC/PLC (115 3%, n 7) comparedwithWT (155
9%, n 8) or trkBWT/WT (148 4%, n 7) control mice. Slices isolated from trkBWT/WTmice
exhibited increases of fEPSP (148 4%, n 7) similar to wild-type animals (/) (155
9%, n 8). Scale bar, 0.25mV, 25ms. Bottom, By contrast, no differences in HFS-induced LTP
of the mf-CA3 pyramid synapse were detected in trkBSHC/SHC compared with WT control mice
(/, 144 7%, n 6; trkBSHC/SHC, 145 7%, n 5, p 0.05, Student’s t test). Scale bar,
0.5 mV, 25 ms.
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and cellularmechanism contributing to limbic epilepsy. Interest-
ingly, in vitro studies reveal that TrkB-mediated activation of
PLC1 signaling can suppress KCC2 expression (Rivera et al.,
2002, 2004). Whether TrkB-mediated activation of PLC1 sig-
naling promotes reductions of KCC2 expression described in the
kindling and pilocarpine models (Rivera et al., 2002; Li et al.,
2008) in vivo is unclear.
Our work elucidates a single signaling pathway activated by a
single receptor contributing to limbic epileptogenesis in vivo,
namely TrkB-mediated activation of PLC1.Whereas a pharma-
cological approach would be expected to inhibit PLC1 activated
by diverse membrane receptors, only PLC1 activated by TrkB is
inhibited in the trkBPLC/PLC mutants. That epileptogenesis is in-
hibited in trkBPLC/PLC but not trkBSHC/SHC mice (He et al., 2002)
implies that anti-epileptogenic therapies need not necessarily tar-
get TrkB itself, thereby circumventing potential unwanted con-
sequences of global inhibition of TrkB. Novel downstream
targets suggested by the present findings include PLC1 itself or
uncoupling TrkB from PLC1. Dissecting signaling pathways di-
rectly coupled to a single cell membrane receptor in vivo in mod-
els of CNS disorders may elucidate novel targets for specific and
effective therapeutic intervention.
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